Signal active
Bio
Hobart is a Partner based in San Francisco. He leads the Healthcare and Financial Services sectors for TPG Growth. Matt is currently a board member of Petbarn and iMDsoft. Previous board service includes The Vincraft Group, Schiff Nutrition International, Wil Research and Agraquest.
Prior to joining TPG Growth in 2004, Mr. Hobart was the Vice President of Corporate Development for Critical Path, where he was part of a turnaround team that led Critical Path through a major financial and operational restructuring. Previously, Matt co-founded and served as a Managing Director of Vectis Group, a venture corporation that capitalized and built companies globally, in partnership with leading U.S. technology businesses. Prior to Vectis Group, Mr. Hobart made private equity investments in the US and Europe for the $2.2 billion Morgan Stanley Capital Partners III L.P. and helped raise and invest the $350 million Morgan Stanley Global Emerging Markets Fund.
Location
N/A
Social
Primary Organization
2007
126
62
51
1001-5000
Financial Services, Venture Capital, Finance
Jobs history
0
N/A
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Matthew Hobart is the Co-Managing Partner at TPG Growth, based in United States, North America. With a background in Financial Services, Matthew Hobart has a rich history of leadership and innovation. Matthew Hobart studied MBA unknown @ Stanford University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
1
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
10
Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
---|---|---|---|---|
Feb 22, 2022 | Idaho College of Osteopathic Medicine | Venture Round - Idaho College of Osteopathic Medicine | The Rise Fund | 0 |
Mar 10, 2022 | RefleXion Medical | Series E - RefleXion Medical | The Rise Fund | 80.0M |
Nov 15, 2023 | RefleXion Medical | Venture Round - RefleXion Medical | The Rise Fund | 105.0M |
Jun 17, 2024 | K2 Medical Research | Private Equity Round - K2 Medical Research | TPG | 0 |
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.